Skip to main content
All lobbying filings

CME GROUP, INC.

Lobbying for CME GROUP INC

 Filing 2nd Quarter - Report
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $440,000.00 expenses · posted Jul 17, 2025

Official filing document

 Bills named in this filing 3
 Lobbying activity 3
Agriculture

Issues related to regulation of clearinghouses, swap data repositories, swap execution facilities, and designated contract markets; Issues related to CFTC Funding; Issues related to Derivatives Clearing Market Structure; Issues related to CFTC Reauthorization; Issues related to H.R. 3633 - Digital Asset Market Clarity Act of 2025 (Sec. 101; Definitions under the Securities Act of 1933, Sec. 102; Definitions under the Commodity Exchange Act, Sec. 103; Definitions under this Act, Sec. 107; Commodity Exchange Act savings provisions, Section 401; Commission jurisdiction over digital commodity transactions, and Section 409; Exclusion for Decentralized Finance Activities); Issues related to the Clearing of US Treasury futures.

Financial Institutions/Investments/Securities

Issues related to H.R. 3633 - Digital Asset Market Clarity Act of 2025 (Sec. 101; Definitions under the Securities Act of 1933, Sec. 102; Definitions under the Commodity Exchange Act, Sec. 103; Definitions under this Act, Sec. 107; Commodity Exchange Act savings provisions, Section 401; Commission jurisdiction over digital commodity transactions, and Section 409; Exclusion for Decentralized Finance Activities); S. 394 - GENIUS Act of 2025 (all issues); H.R. 2392 - STABLE Act of 2025 (all issues); Issues related to Basel III Bank Capital Standards; Issues related to the Clearing of US Treasury futures.

Taxation/Internal Revenue Code

Issues related to tax treatment of futures, securities, and commodities; Issues related to Sec. 1256 of the tax code related to the tax treatment of futures and options.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem